According to a study conducted by researchers at Banaras Hindu University and published in Springer Nature, adolescent girls are at risk of adverse events after receiving Covaxin.
A recent report published in Springer Nature indicates that adolescent girls and individuals with co-morbidities are at a higher risk of adverse events after receiving Bharat Biotech's BBV152 (Covaxin) COVID-19 vaccine. According to the report, nearly one-third of participants in an observational study on the vaccine experienced adverse events of special interest (AESI).
The study, titled "Long-term safety analysis of the BBV152 coronavirus vaccine in adolescents and adults: findings from a one-year prospective study in North India," was conducted by researchers at Banaras Hindu University. It also noted that serious adverse events might occur in 1% of BBV152 recipients, highlighting the need for extended surveillance following vaccination.
In response to a query from The Hindu, Bharat Biotech s...